NASDAQ:PTIX

Protagenic Therapeutics . Common Stock Stock Forecast

etoro logo Buy PTIX
*Your capital is at risk
$0.219
+0.0038 (+1.76%)
At Close: Jul 27, 2026
AI Analysis AI Analysis of PTIX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add PTIX to Watchlist?
  • Easy Tracking In The Watchlist
PDF

High volatility in Protagenic Therapeutics, Inc. Common stock price on Monday which ended trading at $0.219
(Updated on Jul 27, 2026)

Hold candidate since Jul 23, 2026 Gain 1.76%

The Protagenic Therapeutics, Inc. Common stock price gained 1.76% on the last trading day (Monday, 27th Jul 2026), rising from $0.216 to $0.219. During the last trading day the stock fluctuated 40.86% from a day low at $0.177 to a day high of $0.250. The price has been going up and down for this period, and there has been a -15.62% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 12 thousand more shares were traded than the day before. In total, 12 thousand shares were bought and sold for approximately $2.55 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -59.50% during the next 3 months and, with a 90% probability hold a price between $0.0160 and $0.160 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

PTIX Signals & Forecast

There are mixed signals in the stock today. The Protagenic Therapeutics, Inc. Common stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.229 and $0.337. A break-up above any of these levels will issue buy signals. A buy signal was issued from a pivot bottom point on Wednesday, July 08, 2026, and so far it has risen 21.89%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Protagenic Therapeutics, Inc. Common has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Protagenic Therapeutics, Inc. Common stock

Protagenic Therapeutics, Inc. Common finds support from accumulated volume at $0.216 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0725 between high and low, or 40.86%. For the last week, the stock has had daily average volatility of 15.07%.

Our recommended stop-loss: $0.211 (-3.86%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from a pivot bottom found 13 days ago.)

Trading Expectations (PTIX) For The Upcoming Trading Day Of Tuesday 28th

For the upcoming trading day on Tuesday, 28th we expect Protagenic Therapeutics, Inc. Common Stock to open at $0.216, and during the day (based on 14 day Average True Range), to move between $0.204 and $0.235, which gives a possible trading interval of +/-$0.0308 (+/-15.10%) up or down from last closing price. If Protagenic Therapeutics, Inc. Common Stock takes out the full calculated possible swing range there will be an estimated 15.10% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.216 (1.73%) than the resistance at $0.230 (4.83%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Protagenic Therapeutics, Inc. Common Stock stock A Buy?

Protagenic Therapeutics, Inc. Common holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on July 28, 2026 - $0.216 ( 1.72%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

PTIX Performance

Trading levels for PTIX

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.288 31.33%
R2 0.260 18.71%
R1 0.243 10.91%
Price 0.219
S1 0.188 -14.35%
S2 0.171 -22.15%
S3 0.143 -34.77%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0.260 18.51%
R1 0.230 4.83%
Price 0.219
S1 0.216 -1.73%
S2 0.200 -8.84%
S3 0.180 -17.96%

PTIX Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Dec 05, 2005 Dec 05, 2005 Dec 05, 2005 $479,749,712.15 0%

FAQ

What is the symbol for Protagenic Therapeutics, Inc. Common Stock Stock and on which exchange is it traded?
The symbol for Protagenic Therapeutics, Inc. Common Stock is PTIX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Protagenic Therapeutics, Inc. Common Stock Stock?
Protagenic Therapeutics, Inc. Common holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Protagenic Therapeutics, Inc. Common Stock Stock?
Protagenic Therapeutics, Inc. Common Stock Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Protagenic Therapeutics, Inc. Common Stock Stock.

What's the current price of Protagenic Therapeutics, Inc. Common Stock Stock?
As of the end of day on the Jul 27, 2026, the price of an Protagenic Therapeutics, Inc. Common Stock (PTIX) share was $0.219.

What is the 52-week high and low for Protagenic Therapeutics, Inc. Common Stock Stock?
The 52-week high for Protagenic Therapeutics, Inc. Common Stock Stock is $6.20 and the 52-week low is $0.170.

What is the market capitalization of Protagenic Therapeutics, Inc. Common Stock Stock?
As of the Jul 27, 2026, the market capitalization of Protagenic Therapeutics, Inc. Common Stock is 397.16K.
Click to get the best stock tips daily for free!
ABOUT PROTAGENIC THERAPEUTICS, INC. COMMON STOCK
Protagenic Therapeutics . Common Stock
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound is PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company is based in New York, New York....
GOLDEN STAR
Ticker Change Signal Date
KMT
$34.39
2.44% Jul 21
DHT
$17.31
6.59% Jul 13
ROP
$331.60
10.78% Jun 24
JLL
$299.78
8.56% Jun 24
NMRK
$15.02
2.46% Jun 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE